Adults with type 2 diabetes will have a new alternative to daily insulin injections now that the U.S. Food and Drug Administration (FDA) approved a new once-a-week insulin injection.

Governor Greg Abbott delivered remarks at the groundbreaking ceremony for Eli Lilly and Company’s $6.5 billion active ...

Houston's manufacturing sector isn't leaning on one industry to carry it. Life sciences, AI and semiconductors, energy, defense shipbuilding and traditional heavy manufacturing are all expanding at ...

The new campus is expected to reach 35 gigawatts of annual production capacity and create over 400 new jobs in the Houston ...

Eli Lilly's new $6.5 billion facility in Houston will enhance pharmaceutical production and active ingredient manufacturing, part of a $50 billion ...

Eli Lilly and Co. stock (ISIN US5324571083) closed at USD 1,172.05 on the NYSE on September 22, 2026, up 0.61 percent from ...

Sign-ups for Medicare’s GLP-1 coverage plan keep expanding, and Eli Lilly is dominating the market with 70% share, the company’s CEO David Ricks said. | Sign-ups for Medicare’s GLP-1 coverage plan ...

Amid a $50 billion plan to reshore medicine production, Eli Lilly broke ground on a $6.5 billion manufacturing plant in ...

6.5 billion dollar project ...

The FDA took issue with the volume of GLP-1 drugs that Empower produces, suggesting in the warning letter that the changes do ...

Eli Lilly has broken ground on a $6.5B Houston facility expected to create thousands of jobs and manufacture its oral GLP-1 ...

Eli Lilly and Company has broken ground on a $6.5 billion manufacturing facility in Houston, Texas, marking another milestone ...